In The News
Class actions against Ford, Toyota score major win in High Court
Dixon Advisory director reasonably relied on Minters advice, court finds
Slaters HR head says she was fired for reporting systemic underpayments
Fearful of trolling, counsel tapped for Lehrmann wants to stay unnamed
Bid to revive Robodebt class action faces ‘significant hurdles’, says judge
High Court finds curfew, ankle bracelet regime for former detainees unlawful
$405M pelvic mesh settlement distribution can’t ‘drag on’, judge says
In fight to protect UBank brand, NAB wins challenge to UWallet trade mark
MinterEllison brings on seven partners from PwC
Class closure ‘anathema’ to class action regime, contradictors tell High Court
Please login to bookmarkClose

Pharmaceutical giants Merck Sharpe & Dohme and Pfizer have resolved a long-running intellectual property dispute over a 2015 patent owned by Pfizer for a pneumococcal vaccine.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au